Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. — المؤلف: Sherman, Scott K — JAMA oncology 20191206

المؤلف
Sherman, Scott K
النشر
JAMA oncology 20191206
الوصف
236-242 p.
الموضوعات
Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Bevacizumab؛ Capecitabine؛ Colorectal Neoplasms؛ Cost-Benefit Analysis؛ Disease Progression؛ Drug Costs